United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 14, 2026 · Filed Sep 15, 2026

On Sep 14, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$504.12 for US$4.79M under a trading plan, leaving 324,443 shares. Filed Sep 15, 2026 (Form 4).

Sold
9,500 shares
Price
US$504.12 average (US$502.15 to US$506.48)
Value
US$4.79M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 14, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 14, 2026Common StockSale1,580US$502.15332,363Indirect
Sep 14, 2026Common StockSale2,358US$503.44330,005Indirect
Sep 14, 2026Common StockSale2,722US$504.47327,283Indirect
Sep 14, 2026Common StockSale2,400US$505.25324,883Indirect
Sep 14, 2026Common StockSale440US$506.48324,443Indirect

Source

View original at SEC

Related